gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Experimental Mammary Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darrasse, L; Ginefri, JC; Poirier-Quinot, M; Robert, P | 1 |
| Feng, Y; Guo, J; Ke, T; Lu, ZR; Parker, DL | 1 |
| Bonnet, PA; Boucard, M; Chapat, JP; Cyteval, C; Fernandez, JP; Lamarque, JL; Michel, A; Rifai, A | 1 |
3 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Contrast-enhanced dynamic MRI protocol with improved spatial and time resolution for in vivo microimaging of the mouse with a 1.5-T body scanner and a superconducting surface coil.
Topics: Animals; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Organometallic Compounds; Sensitivity and Specificity | 2005 |
Biodegradable cystamine spacer facilitates the clearance of Gd(III) chelates in poly(glutamic acid) Gd-DO3A conjugates for contrast-enhanced MR imaging.
Topics: Absorbable Implants; Animals; Cystamine; Disulfides; Female; Heterocyclic Compounds; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Molecular Structure; Organometallic Compounds; Polyglutamic Acid; Random Allocation; Structure-Activity Relationship | 2006 |
The use of Gd-DOTA in magnetic resonance imaging of experimentally induced mammary tumors.
Topics: Adenocarcinoma; Animals; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Organometallic Compounds; Rats; Rats, Inbred Strains; Time Factors | 1990 |